Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-14
2011-12-06
Andres, Janet (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08071772
ABSTRACT:
Compounds of formula I:(wherein variables A1, A2, A3, A4, A5, A6, A7, B, E1, E2, E3, E4, E5, G1, G2, J and K are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
REFERENCES:
patent: 5436261 (1995-07-01), Cordi et al.
patent: 6057335 (2000-05-01), Fukami et al.
patent: 6638942 (2003-10-01), Gao et al.
patent: 2004/0186155 (2004-09-01), Dayno et al.
patent: WO 2004/082605 (2004-09-01), None
patent: 2006/031610 (2006-03-01), None
patent: WO 2007/061676 (2007-05-01), None
patent: WO 2007/061677 (2007-05-01), None
patent: WO 2007/061692 (2007-05-01), None
patent: WO 2007/061695 (2007-05-01), None
Martin, Yvonne C. et al., Do Structurally Similar Molecules Have Similar Biological Activity?, 45 J. Med. Chem., 4350-4358, 4536 (2002).
Wood et al., Novel CGRP Receptor Antagonists Through a Design Strategy of Target Simplification with Addition of Molecular Flexibility, 19 Bioorg & Med. Chem. Letts., 5787-5790 (2009).
Khan, et al., “A Novel and Expeditious Approach to Unusual Spirolactam Building Blocks,” J. Org. Chem., vol. 68, 2003, pp. 4556-4559.
Supplementary European search report and search opinion for counterpart EP Application No. 06 83 7582.
International Preliminary Report on Patentability for PCT/US2006/044212.
Bell Ian M.
Selnick Harold G.
Stump Craig A.
Theberge Cory R.
Zartman C. Blair
Andres Janet
Devlin Gerard M.
Merck Sharp & Dohme Corp.
Rozof Timothy R
Yuro Raynard
LandOfFree
Spirolactam bicyclic CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spirolactam bicyclic CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirolactam bicyclic CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4310908